TITLE

Current Concepts in the Pharmacological Management of Obesity

AUTHOR(S)
Carek, P.J.; Dickerson, L.M.
PUB. DATE
June 1999
SOURCE
Drugs;Jun1999, Vol. 57 Issue 6, p883
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The pharmacological management of obesity has gained increasing attention as new weight loss treatments are approved and a significant proportion of the public strives to lose weight. Obesity is associated with a high mortality rate, multiple chronic medical conditions, and carries an enormous financial burden. Obesity is a multifactorial condition, most often due to an imbalance in energy intake and expenditure. Despite the greater focus on management of obesity, weight loss remains a difficult goal to achieve. Obesity is a chronic medical condition that may require long term treatment, therefore the risks and benefits of all pharmacological agents must be carefully considered. Noradrenergic appetite suppressants (ie. phenylpropanolamine, phentermine) result in weight loss but stimulatory effects limit their use. The serotonergic agents (fenfluramine , dexfenfluramine) were effective weight loss drugs, but were voluntarily withdrawn from the US market last year because of cardiovascular and pulmonary complications. The combination noradrenergic/serotonergic agent sibutramine is indicated for the management of obesity, particularly in the presence of other cardiovascular risk factors. Modest weight loss is achieved with sibutramine, although weight gain is significant after discontinuation. In addition, long term safety data are not yet available. The thermogenic combination of ephedrine plus caffeine is minimally effective, and adverse effects are usually transient. Other thermogenic agents, such as β-agonists, are still under investigation. Agents may alter digestion through lipase inhibition (orlistat) or fat substitution (olestra). Orlistat decreases systemic absorption of dietary fat, decreasing body weight and cholesterol. Olestra is a fat substitute that has been incorporated into snack foods. Olestra substitution for dietary fat has not been studied as a weight loss strategy, although olestra has no caloric value and may be beneficial. The use of orlistat and olestra may be limited by gastrointestinal adverse effects. Finally, the manipulation of leptin and neuropeptide Y are under investigation for the treatment of obesity. Pharmacological agents should be used as an aid to a structured diet and exercise regimen in the treatment of obesity. Weight loss agents may result in initial weight loss, but sustained weight loss is not always achieved even with continuation of treatment. The effect of weight loss obtained while using pharmacotherapeutic agents on morbidity and mortality has not been established. Therefore, diet and exercise should be the focus of any weight loss programme. There is a continued need for safe and effective pharmacotherapeutic agents for the treatment of obesity.
ACCESSION #
9593063

 

Related Articles

  • Lorcaserin: A novel antiobesity drug. Brashier, Dick B. S.; Sharma, A. K.; Navdeep Dahiya; Singh, S. K.; Anjan Khadka // Journal of Pharmacology & Pharmacotherapeutics;Apr-Jun2014, Vol. 5 Issue 2, p175 

    Obesity is a major co-morbidity with hypertension and diabetes mellitus. There are few drugs for treatment of obesity like orlistat and recentlty approved drug lorcaserin. Lorcaserin has serotonergic properties and acts as an anorectic. It may cause serious side effects, including serotonin...

  • THE NEW PRESCRIPTIONS.  // Marie Claire (US Edition);Oct2012, Vol. 19 Issue 10, p270 

    The article offers a preview on the two diet medications approved by the U.S. Food and Drug Administration (FDA), the Belviq and the combined phentermine and topiramate drug called Qsymia and another drug, the Contrave, which is to be reviewed by the agency after it was rejected in 2011.

  • ANOREXIGENIC DRUGS IN THE TREATMENT OF OBESITY: PAST, PRESENT AND FUTURE. Ştefania, Todea; Gabriel, Hancu // Acta Medica Marisiensis;2019 Supplement, Vol. 65, p69 

    Background: Obesity is a medical condition in which the subject carries an excess weight; and represents a great problem in modern society. Obesity is related to multiple reasons, including diet, lifestyle, pathological conditions, genetic factors or the use of certain medications. It can...

  • OBESITY DRUGS Not a Quick Fix.  // USA Today Magazine;Oct2000, Vol. 129 Issue 2665, p6 

    Provides information on the use of diet pills to reduce the weight of obese patients. Complications and side effects of diet pills; Benefits of diet and exercise therapy; Observation on the lifestyle of obese patients.

  • orlistat. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p569 

    An encyclopedia entry for "orlistat" is presented. It refers to an anti-obesity drug used with a slimming diet for the treatment of severe obesity. It is different from appetite suppressants in that orlistat acts on the gastrointestinal tract, preventing the digestion of fats by lipases. The...

  • Pharmacology of Appetite Suppression: Implication for the Treatment of Obesity. Halford, Jason C.G. // Current Drug Targets;Dec2001, Vol. 2 Issue 4, p353 

    Given the current global epidemic of obesity there is a demand for new anti-obesity drugs to overcome the problem. Many pharmacological agents reduce food intake and significantly decrease body mass when administered to animals but affect feeding behaviour in a profoundly different way...

  • Options for treating obesity. Campbell, Ian // GP: General Practitioner;4/26/2002, p70 

    Focuses on the options for general practitioners in treating obesity. Effectiveness of anti-obesity drugs; Requirements for drug administration; Importance of setting realistic targets.

  • Long-Term Results of Drug Treatment for Obesity. SLAWSON, DAVID // American Family Physician;3/1/2014, Vol. 89 Issue 5, p389 

    The article presents answers to a question on whether weight loss medications are effective as long-term treatment for obesity.

  • 5 that work. Nachatelo, Melissa // Natural Health;May/Jun2001, Vol. 31 Issue 4, p70 

    Presents information about different natural diet supplements used in the management of obesity. Green tea; Ephedra; Chromium.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics